The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer

被引:6
作者
Bragina, Olga D. [1 ,2 ]
Deyev, Sergei M. [2 ,3 ]
Chernov, Vladimir, I [1 ,2 ]
Tolmachev, Vladimir M. [2 ,4 ]
机构
[1] Russian Acad Sci, Canc Res Inst, Tomsk Natl Res Med Ctr, Tomsk 634009, Russia
[2] Natl Res Tomsk Polytech Univ, Tomsk 634050, Russia
[3] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
[4] Uppsala Univ, Uppsala, Sweden
来源
ACTA NATURAE | 2022年 / 14卷 / 02期
关键词
breast cancer; HER2/neu; radionuclide diagnostics; monoclonal antibody; alternative scaffold proteins; HER2; EXPRESSION; THERAPEUTIC TARGETS; RECEPTOR; THERANOSTICS; TRASTUZUMAB; DISCORDANCE; CONCORDANCE; METASTASES; BIOMARKERS; GUIDELINES;
D O I
10.32607/actanaturae.11611
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review examines the evolution of the radionuclide diagnosis of HER2-positive breast cancer using various compounds as a targeting module in clinical practice: from full-length antibodies to a new group of small synthetic proteins called alternative scaffold proteins. This topic is of especial relevance today in view of the problems attendant to the detection of breast cancer with HER2/neu overexpression, which, in most cases, introduce errors in the treatment of patients. The results of clinical studies of radiopharmaceuticals based on affibody molecules, ADAPTs, and DARPins for SPECT and PET have demonstrated good tolerability of the compounds, their rapid excretion from the body, and the possibility to differentiate tumor sites depending on the HER2/neu status. This indicates that targeted radionuclide diagnosis holds promise and the need to continue research in this direction.
引用
收藏
页码:4 / 15
页数:12
相关论文
共 88 条
  • [51] Bone metastases incidence and its correlation with hormonal and human epidermal growth factor receptor 2 neu receptors in breast cancer
    Pareek, Ananya
    Singh, O. P.
    Yogi, Veenita
    Ghori, H. U.
    Tiwari, Vivek
    Redhu, Pallavi
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (05) : 971 - 975
  • [52] Parkin D. M., 1999, CA Cancer J. Clin, V49, P33, DOI [DOI 10.3322/CANJCLIN.49.1.33, 10.3322/canjclin.49.1.33, DOI 10.3322/CAAC.21492]
  • [53] Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits
    Pekar, Gyula
    Kasselaki, Ionna
    Pekar-Lukacs, Agnes
    Dekany, Csaba
    Hellberg, Dan
    Tot, Tibor
    [J]. HISTOPATHOLOGY, 2019, 74 (02) : 300 - 310
  • [54] Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Perik, Patrick J.
    Lub-De Hooge, Marjolijn N.
    Gietema, Jourik A.
    van der Graaf, Winette T. A.
    de Korte, M. Alexander
    Jonkman, Sharon
    Kosterink, Jos G. W.
    van Veldhuisen, Dirk J.
    Sleijfer, Dirk T.
    Jager, Pieter L.
    de Vries, Elisabeth G. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2276 - 2282
  • [55] HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance
    Pernas, Sonia
    Tolaney, Sara M.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [56] Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
    Plueckthun, Andreas
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 489 - 511
  • [57] Raica M, 2014, ANTICANCER RES, V34, P1435
  • [58] Sachdev JC, 2019, CANCER TREAT RES, V178, P45, DOI 10.1007/978-3-030-16391-4_2
  • [59] Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT
    Sandberg, Dan
    Tolmachev, Vladimir
    Velikyan, Irina
    Olofsson, Helena
    Wennborg, Anders
    Feldwisch, Joachim
    Carlsson, Jorgen
    Lindman, Henrik
    Sorensen, Jens
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) : 1337 - 1346
  • [60] Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients
    Sandstrom, Mattias
    Lindskog, Karolina
    Velikyan, Irma
    Wennborg, Anders
    Feldwisch, Joachim
    Sandberg, Dan
    Tolmachev, Vladimir
    Orlova, Anna
    Sorensen, Jens
    Carlsson, Jorgen
    Lindman, Henrik
    Lubberink, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 867 - 871